Cargando…
Inhibition of HGF/MET signaling decreases overall tumor burden and blocks malignant conversion in Tpl2-related skin cancer
Tumor progression locus 2 (Tpl2) is a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family of serine/threonine kinases. Deletion of the Tpl2 gene is associated with a significantly higher number of papillomas and cutaneous squamous cell carcinomas (cSCCs). Overexpression of he...
Autores principales: | Bonan, Nicole F., Kowalski, David, Kudlac, Kaitie, Flaherty, Kira, Gwilliam, J. Curtis, Falkenberg, Lauren G., Maradiaga, Erik, DeCicco-Skinner, Kathleen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328619/ https://www.ncbi.nlm.nih.gov/pubmed/30631034 http://dx.doi.org/10.1038/s41389-018-0109-8 |
Ejemplares similares
-
Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes
por: Kelley, Mary B., et al.
Publicado: (2022) -
Altered Prostanoid Signaling Contributes to Increased Skin Tumorigenesis in Tpl2 Knockout Mice
por: DeCicco-Skinner, Kathleen L., et al.
Publicado: (2013) -
HGF-MET as a breast cancer biomarker
por: Liu, Shuying
Publicado: (2015) -
HGF/c-MET Signaling in Melanocytes and Melanoma
por: Czyz, Malgorzata
Publicado: (2018) -
HGF–Met Pathway in Regeneration and Drug Discovery
por: Matsumoto, Kunio, et al.
Publicado: (2014)